Evolving use of B-type natriuretic peptide in clinical practice.

renal failure: standards and audit measures (third edition). London: UK Renal Association, 2002. 2. Walker KS, Seth J. Stability of parathyroid hormone in blood from renal patients on haemodialysis. Ann Clin Biochem 2000;37:800–1. 3. Omar H, Chamberlin A, Walker V, Wood PJ. Immulite 2000 parathyroid hormone assay: stability of parathyroid hormone in EDTA blood kept at room temperature for 48 hours. Ann Clin Biochem 2001;38:561–3. 4. Teal TK, Reed M, Stevens PE, Lamb EJ. Stability of parathyroid hormone ex vivo in haemodialysis patients. Ann Clin Biochem 2003;40:191–3. 5. Levin GE, Nisbet JA. Stability of parathyroid hormone related protein and parathyroid hormone at room temperature. Ann Clin Biochem 1994;31:497–500. 6. Inaba M, Nakatsuka K, Imanishi Y, Watanabe M, Mamiya Y, Ishimura E, et al. Technical and clinical characterization of the Bio-PTH (1–84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone. Clin Chem 2004;50:385–90. 7. Nussbaum SR, Zahradnik RL, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987; 33:1364–7. 8. D’Amour P, Brossard J-H, Rousseau L, Roy L, Gao P, Cantor T. Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1–84) is overproduced in primary and secondary hyperparathyroidism. Clin Chem 2003;49:2037–44.